KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,445,350 | +156.2% | 115,000 | +228.6% | 2.59% | +151.4% |
Q2 2023 | $7,589,750 | -58.2% | 35,000 | -65.0% | 1.03% | -60.3% |
Q1 2023 | $18,164,000 | -38.4% | 100,000 | -33.3% | 2.60% | -24.7% |
Q4 2022 | $29,475,000 | -12.6% | 150,000 | 0.0% | 3.45% | -16.8% |
Q3 2022 | $33,740,000 | +77.8% | 150,000 | 0.0% | 4.15% | +19.1% |
Q2 2022 | $18,977,000 | -56.0% | 150,000 | -55.9% | 3.48% | -37.7% |
Q1 2022 | $43,109,000 | +9.7% | 340,000 | +13.3% | 5.59% | +37.9% |
Q4 2021 | $39,300,000 | -30.2% | 300,000 | -34.8% | 4.05% | -0.1% |
Q3 2021 | $56,272,000 | +51.9% | 460,000 | +41.5% | 4.06% | +30.3% |
Q2 2021 | $37,047,000 | +54.1% | 325,000 | +62.5% | 3.11% | +32.7% |
Q1 2021 | $24,046,000 | +97.2% | 200,000 | +66.7% | 2.35% | +124.6% |
Q4 2020 | $12,191,000 | +143.1% | 120,000 | +72.3% | 1.04% | -45.2% |
Q1 2020 | $5,015,000 | +67.9% | 69,658 | +75.7% | 1.91% | +159.2% |
Q4 2019 | $2,987,000 | – | 39,647 | – | 0.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 908,708 | $109,254,000 | 35.05% |
Sofinnova Investments, Inc. | 1,952,441 | $234,742,000 | 14.11% |
Logos Global Management LP | 200,000 | $24,046,000 | 2.35% |
First Light Asset Management, LLC | 258,500 | $31,079,000 | 2.06% |
Eventide Asset Management | 971,077 | $116,753,000 | 1.73% |
DAFNA Capital Management LLC | 48,000 | $5,771,000 | 1.37% |
CATALYST PRIVATE WEALTH, LLC | 13,006 | $1,564,000 | 1.10% |
Rock Springs Capital Management LP | 368,764 | $44,336,000 | 0.97% |
Pinz Capital Management, LP | 28,805 | $3,463,000 | 0.92% |
MILLER VALUE PARTNERS, LLC | 291,239 | $35,016,000 | 0.91% |